vascepa

Showing 3 posts of 3 posts found.

fda2outsideweb

Label expansion of Amarin’s Vascepa has unanimous backing of FDA advisory panel

November 15, 2019
Medical Communications, Sales and Marketing Amarin, FDA, vascepa

The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted in favour of expanding the existing approval of Irish …

vascepa

COMMENT: What does Amarin’s off-patent victory over the FDA mean for the industry?

March 14, 2016
Medical Communications, Sales and Marketing Amarin, FDA, off label, off-label, vascepa

Last week, Pharmafile.com reported that small biopharma Amarin had settled litigation with US drugs regulator the FDA that will allow …

amarin_logo

Amarin wins case against FDA to promote Vascepa for off-label uses

March 10, 2016
Medical Communications, Research and Development, Sales and Marketing Amarin, FDA, first amendment, off label, vascepa

Amarin has announced a settlement with the US Food and Drug Administration (FDA) that resolves the dispute over the Irish-based …

The Gateway to Local Adoption Series

Latest content